Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Durogesic D-TRANS in Cancer Pain Patients With Inadequately Controlled Pain Relief From Weak Opioids

NCT01060124 is registered in ClinicalTrials.gov with Janssen Korea, Ltd., Korea as lead sponsor.

NCT NCT01060124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01060124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Durogesic D-TRANS in Cancer Pain Patients With Inadequately Controlled Pain Relief From Weak Opioids
Lead sponsor
Janssen Korea, Ltd., Korea
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2007
Completion date
February 28, 2009
Enrollment
103 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pain; cancer